Mapi Pharma Ltd.
Clinical trials sponsored by Mapi Pharma Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New monthly shot could simplify mental health treatment Results expected Dec 2026 (estimated)
-
New diabetes shot could cut injections to once a month
Disease control Recruiting nowThis study tests a new, long-acting form of semaglutide (a diabetes drug) that is given once every four weeks instead of weekly. The goal is to see if it is safe and works well for controlling blood sugar and weight in 24 adults with type 2 diabetes. Participants must already be …
Phase 1/2 • Sponsor: Mapi Pharma Ltd. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New monthly shot could simplify mental health treatment
Disease control Recruiting nowThis study tests a long-acting injection of cariprazine given once a month, instead of daily pills, for people with schizophrenia, bipolar I disorder, or major depression. The trial involves 24 clinically stable adults and will check safety, side effects, and how well the drug wo…
Phase 1/2 • Sponsor: Mapi Pharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC